Lawver Teri L
- SEC CIK
- 0001960596
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDX Celldex Therapeutics, Inc.SVP & Chief Commercial Officeras of Jun 29, 2026
- ALT Altimmune, Inc.Directoras of May 1, 2026
- DXCM Dexcom IncEVP Chief Commercial Officeras of Mar 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lawver Teri L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DXCM Dexcom Inc
EVP Chief Commercial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 (view filing) | Mar 12 | 2 days | Lawver Teri LEVP Chief Commercial Officer | SSale | −4.76K | $134.41 | −$640.3K | −6.7%66.6K after |